1474 related articles for article (PubMed ID: 24470529)
1. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
2. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
3. Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.
Skoglund PH; Höijer J; Ärnlöv J; Zethelius B; Svensson P
Hypertension; 2015 Sep; 66(3):681-6; discussion 445. PubMed ID: 26150437
[TBL] [Abstract][Full Text] [Related]
4. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
[TBL] [Abstract][Full Text] [Related]
6. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.
Mueller T; Hinterreiter F; Luft C; Poelz W; Haltmayer M; Dieplinger B
J Vasc Surg; 2014 May; 59(5):1291-9. PubMed ID: 24393280
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
[TBL] [Abstract][Full Text] [Related]
10. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
11. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels.
Carrasco-Sánchez FJ; Pérez-Calvo JI; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio I; Barón-Franco B; Aguayo-Canela M; Pujol-De la llave E
J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):115-21. PubMed ID: 24522084
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory pulse pressure predicts cardiovascular events in patients with peripheral arterial disease.
Skoglund PH; Östergren J; Svensson P
Blood Press; 2012 Aug; 21(4):227-32. PubMed ID: 22553945
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of C-reactive protein as an inflammatory and N-terminal probrain natriuretic peptide as a neurohumoral marker in acute heart failure (from the Korean Heart Failure registry).
Park JJ; Choi DJ; Yoon CH; Oh IY; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Yoo BS; Kang SM; Oh BH;
Am J Cardiol; 2014 Feb; 113(3):511-7. PubMed ID: 24315115
[TBL] [Abstract][Full Text] [Related]
15. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
Rothenbacher D; Koenig W; Brenner H
Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
[TBL] [Abstract][Full Text] [Related]
20. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
